Nalaganje...

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

More accurate criteria are required for the selection of patients with node-negative breast cancer for systemic adjuvant therapy. Expression of epidermal growth factor receptor (EGFr) has been shown previously to be inversely related to oestrogen receptor (ER) in patients with operable breast cancer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Nicholson, S., Richard, J., Sainsbury, C., Halcrow, P., Kelly, P., Angus, B., Wright, C., Henry, J., Farndon, J. R., Harris, A. L.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1991
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1971641/
https://ncbi.nlm.nih.gov/pubmed/1846551
Oznake: Označite
Brez oznak, prvi označite!